These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade. Schmidt ME, Matochik JA, Goldstein DS, Schouten JL, Zametkin AJ, Potter WZ. Neuropsychopharmacology; 1997 Apr; 16(4):298-310. PubMed ID: 9094148 [Abstract] [Full Text] [Related]
3. Reproducibility of regional brain metabolic responses to lorazepam. Wang GJ, Volkow ND, Overall J, Hitzemann RJ, Pappas N, Pascani K, Fowler JS. J Nucl Med; 1996 Oct; 37(10):1609-13. PubMed ID: 8862292 [Abstract] [Full Text] [Related]
4. Idazoxan-induced reductions in cortical glucose use are accompanied by an increase in noradrenaline release: complementary [14C]2-deoxyglucose and microdialysis studies. French N, Lalies MD, Nutt DJ, Pratt JA. Neuropharmacology; 1995 Jun; 34(6):605-13. PubMed ID: 7566496 [Abstract] [Full Text] [Related]
5. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. Heiss WD, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K. J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929 [Abstract] [Full Text] [Related]
6. Effects of percent thresholding on the extraction of [18F]fluorodeoxyglucose positron emission tomographic region-of-interest data. Rottenberg DA, Moeller JR, Strother SC, Dhawan V, Sergi ML. J Cereb Blood Flow Metab; 1991 Mar; 11(2):A83-8. PubMed ID: 1997493 [Abstract] [Full Text] [Related]
7. Cerebral glucose metabolic differences in patients with panic disorder. Nordahl TE, Semple WE, Gross M, Mellman TA, Stein MB, Goyer P, King AC, Uhde TW, Cohen RM. Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544 [Abstract] [Full Text] [Related]